Nere, Marites D.

HRN: 15-35-75  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/18/2025
CEFUROXIME 500MG (TAB)
09/18/2025
09/24/2025
PO
500 Mg
BID
Thickly MSAF
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines